Objective To explore the effects of Jingling Oral Liquid(mainly composed of Polygoni Multiflori Radix,Polygonati Rhizoma,Platycladi Semen,Nelumbinis Semen,Ligustri Lucidi Fructus,Poria,and Lilii Bulbus)as an adjunctive therapy on cognitive,motor,and social abilities in children with global developmental delay(GDD).Methods A total of 120 children with GDD who visited the Department of Neurological Rehabilitation at Hebei Children's Hospital from July 2021 to November 2023 were selected as the study subjects.The children were randomly divided into a control group and a trial group using a random number table,with 60 children in each group.The control group received conventional comprehensive rehabilitation training,while the trial group received Jingling Oral Liquid as an adjunctive therapy in addition to the control group's treatment.The treatment course lasted 12 weeks.Before and after treatment,the changes in Gesell Developmental Scale(GDS)scores,Peabody Developmental Motor Scales(PDMS)scores,motor function scores,and language ability scores in both groups were observed to evaluate the cognitive,motor,and social abilities of the children.Results(1)After treatment,the scores of all dimensions of the GDS,including adaption,developmental quotient of fine motor,language developmental quotient,and personal-social developmental quotient,were significantly increased in both groups compared to those before treatment(P＜0.01),and the improvement of GDS scores in the trial group was significantly superior to that in the control group(P＜0.01).(2)After treatment,the scores of all dimensions of the PDMS,including fine developmental quotient score,standardized score of visual-motor integration,and standardized score of grasping,were significantly increased in both groups compared to those before treatment(P＜0.01),and the improvement of PDMS scores in the trial group was significantly superior to that in the control group(P＜0.01).(3)After treatment,the scores of motor function indicators of fine motor quotient(FMQ),gross motor quotient(GMQ),and total motor quotient(TMQ)were significantly increased in both groups compared to those before treatment(P＜0.01),and the improvement of motor function scores in the trial group was significantly superior to that in the control group(P＜0.01).(4)After treatment,the language ability scores were significantly increased in both groups compared to those before treatment(P＜0.01),and the improvement of language ability scores in the trial group was significantly superior to that in the control group(P＜0.01).Conclusion The combination of Jingling Oral Liquid with conventional comprehensive rehabilitation training can effectively improve the cognitive,motor,and social abilities of children with GDD.

Advanced nasopharyngeal carcinoma accounts for about 70% of newly diagnosed nasopharyngeal carcinoma cases. Although radiochemotherapy can effectively control the progression of nasopharyngeal carcinoma, the prognosis remains poor, and recurrence and metastasis may lead to treatment failure in advanced nasopharyngeal carcinoma. Overall, the current treatment status of advanced nasopharyngeal carcinoma is not optimistic. Nimotuzumab exerts a tumor-suppressive effect by targeting the epidermal growth factor receptor. Recent studies have found that nimotuzumab combined with radiochemotherapy can effectively control tumor progression in advanced nasopharyngeal carcinoma. This article summarizes the research progress of nimotuzumab combined with radiochemotherapy in the treatment of advanced, metastatic, and recurrent nasopharyngeal carcinoma, so as to provide references for the research and clinical application of nimotuzumab.

Advanced nasopharyngeal carcinoma accounts for about 70% of newly diagnosed nasopharyngeal carcinoma cases. Although radiochemotherapy can effectively control the progression of nasopharyngeal carcinoma, the prognosis remains poor, and recurrence and metastasis may lead to treatment failure in advanced nasopharyngeal carcinoma. Overall, the current treatment status of advanced nasopharyngeal carcinoma is not optimistic. Nimotuzumab exerts a tumor-suppressive effect by targeting the epidermal growth factor receptor. Recent studies have found that nimotuzumab combined with radiochemotherapy can effectively control tumor progression in advanced nasopharyngeal carcinoma. This article summarizes the research progress of nimotuzumab combined with radiochemotherapy in the treatment of advanced, metastatic, and recurrent nasopharyngeal carcinoma, so as to provide references for the research and clinical application of nimotuzumab.